BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32181991)

  • 1. Fe-Doped Polyoxometalate as Acid-Aggregated Nanoplatform for NIR-II Photothermal-Enhanced Chemodynamic Therapy.
    Shi Y; Zhang J; Huang H; Cao C; Yin J; Xu W; Wang W; Song X; Zhang Y; Dong X
    Adv Healthc Mater; 2020 May; 9(9):e2000005. PubMed ID: 32181991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-responsive enzymatic biomimetic nanodots for H
    Xu Y; Bian J; Liu X; Qian Z; Sun M; Zhang C; Pan R; Li Q; Sun C; Lin B; Peng K; Lu N; Yao X; Fan W
    Acta Biomater; 2023 Dec; 172():441-453. PubMed ID: 37802309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An acidity-responsive polyoxometalate with inflammatory retention for NIR-II photothermal-enhanced chemodynamic antibacterial therapy.
    Shi Y; Yin J; Peng Q; Lv X; Li Q; Yang D; Song X; Wang W; Dong X
    Biomater Sci; 2020 Nov; 8(21):6093-6099. PubMed ID: 33001068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near infrared II excitation nanoplatform for photothermal/chemodynamic/antibiotic synergistic therapy combating bacterial biofilm infections.
    Wang X; Zhang C; He L; Li M; Chen P; Yang W; Sun P; Li D; Zhang Y
    J Nanobiotechnology; 2023 Nov; 21(1):446. PubMed ID: 38001486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional MnO
    Wang Q; Qu B; Li J; Liu Y; Dong J; Peng X; Zhang R
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):4980-4994. PubMed ID: 35050589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mo
    Liu G; Zhu J; Guo H; Sun A; Chen P; Xi L; Huang W; Song X; Dong X
    Angew Chem Int Ed Engl; 2019 Dec; 58(51):18641-18646. PubMed ID: 31605417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy.
    Zhou S; Xu J; Dai Y; Wei Y; Chen L; Feng W; Chen Y; Ni X
    Biomater Res; 2022 Nov; 26(1):66. PubMed ID: 36435848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy.
    Ye S; Xiao H; Chen J; Zhang D; Qi L; Peng T; Gao Y; Zhang Q; Qu J; Wang L; Liu R
    Int J Nanomedicine; 2023; 18():1245-1257. PubMed ID: 36937549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ellagic acid-Fe@BSA nanoparticles for endogenous H
    Tian Q; An L; Tian Q; Lin J; Yang S
    Theranostics; 2020; 10(9):4101-4115. PubMed ID: 32226542
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor Cell Targeting and Responsive Nanoplatform for Multimodal-Imaging Guided Chemodynamic/Photodynamic/Photothermal Therapy toward Triple Negative Breast Cancer.
    Li L; Li J; Hu R; Zhang X; Ding L; Ren G; Liu W; Wang H; Wang B; Zhang C; Diao H
    ACS Appl Mater Interfaces; 2023 Jun; 15(23):27706-27718. PubMed ID: 37261936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metal-phenolic network-based multifunctional nanocomposite with pH-responsive ROS generation and drug release for synergistic chemodynamic/photothermal/chemo-therapy.
    Meng X; Chen L; Lv R; Liu M; He N; Wang Z
    J Mater Chem B; 2020 Mar; 8(10):2177-2188. PubMed ID: 32096524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An engineered cascade-sensitized red-emitting upconversion nanoplatform with a tandem hydrophobic hydration-shell and metal-phenolic network decoration for single 808 nm triggered simultaneous tumor PDT and PTT enhanced CDT.
    Li Y; Ding Y; Zhang Y; Sun Z; Liu J; Dai M; Feng J; Li B; Wang C; Wei Y; Shen JW
    Nanoscale; 2023 Jun; 15(23):10067-10078. PubMed ID: 37249048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Efficient 2D NIR-II Photothermal Agent with Fenton Catalytic Activity for Cancer Synergistic Photothermal-Chemodynamic Therapy.
    Zhang Q; Guo Q; Chen Q; Zhao X; Pennycook SJ; Chen H
    Adv Sci (Weinh); 2020 Apr; 7(7):1902576. PubMed ID: 32274298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-Targeting MoS
    Li X; Xiao H; Xiu W; Yang K; Zhang Y; Yuwen L; Yang D; Weng L; Wang L
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55928-55938. PubMed ID: 34786942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-chelated semiconducting oligomer nanoparticles for NIR-II fluorescence imaging-guided enhanced chemodynamic/photothermal combination therapy.
    Diao S; Shi W; Liu Y; Liang T; Xu Z; Zhou W; Xie C; Fan Q
    J Mater Chem B; 2023 Oct; 11(38):9290-9299. PubMed ID: 37727138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIR-II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases.
    Sun P; Qu F; Zhang C; Cheng P; Li X; Shen Q; Li D; Fan Q
    Adv Sci (Weinh); 2022 Nov; 9(33):e2204718. PubMed ID: 36216756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering Cu
    Du K; Zhao S; Feng J; Gao X; Liu K; Wang X; Zhang M; Li Y; Lu Y; Zhang H
    J Mater Chem B; 2021 Sep; 9(35):7216-7228. PubMed ID: 35226035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional CuFe
    Chen N; Li Y; Li H; Wang Y; Zeng Y; Zhang M; Pan Z; Chen Z; Liang W; Huang J; Zhang K; Liu X; He Y
    Colloids Surf B Biointerfaces; 2023 Sep; 229():113445. PubMed ID: 37441838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation.
    Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y
    Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-Infrared II Plasmonic Phototheranostics with Glutathione Depletion for Multimodal Imaging-Guided Hypoxia-Tolerant Chemodynamic-Photocatalytic-Photothermal Cancer Therapy Triggered by a Single Laser.
    Shan B; Liu H; Li L; Lu Y; Li M
    Small; 2022 Jan; 18(4):e2105638. PubMed ID: 34821041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.